Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects

NCT06084663 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis and Psoriatic Arthritis

Interventions

DRUG: Apremilast 30 mg Tablets
DRUG: Otezla 30 mg film-coated tablets

Sponsor

Humanis Saglık Anonim Sirketi